Savara SG&A Expense (TTM) Trends | YCharts

Savara, Inc. (SVRA)

5.37 0.00 (0.00%) USD | NASDAQ | Sep 04, 16:00

5.39 +0.02 (+0.37%) After-Hours: 20:00

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for SVRA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View SG&A Expense (TTM) Chart

Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2001. Start Trial.

Date	Value
June 30, 2026	56.71M
March 31, 2026	48.38M
December 31, 2025	42.06M
September 30, 2025	37.38M
June 30, 2025	33.76M
March 31, 2025	28.65M
December 31, 2024	25.04M
September 30, 2024	22.04M
June 30, 2024	20.18M
March 31, 2024	17.94M
December 31, 2023	15.67M
September 30, 2023	14.06M
June 30, 2023	12.29M
March 31, 2023	11.94M
December 31, 2022	10.93M
September 30, 2022	10.71M
June 30, 2022	11.73M
March 31, 2022	11.93M
December 31, 2021	12.35M
September 30, 2021	12.12M
June 30, 2021	14.10M
March 31, 2021	14.06M
December 31, 2020	14.26M
September 30, 2020	14.77M
June 30, 2020	12.21M

Date	Value
March 31, 2020	13.30M
December 31, 2019	13.08M
September 30, 2019	13.04M
June 30, 2019	13.37M
March 31, 2019	11.65M
December 31, 2018	10.66M
September 30, 2018	10.17M
June 30, 2018	8.512M
March 31, 2018	11.11M
December 31, 2017	11.08M
September 30, 2017	9.175M
June 30, 2017	8.691M
March 31, 2017	4.211M
December 31, 2016	5.31M
September 30, 2016	6.96M
June 30, 2016	8.418M
March 31, 2016	10.22M
December 31, 2015	10.96M
September 30, 2015	10.84M
June 30, 2015	10.84M
March 31, 2015	10.80M
December 31, 2014	9.488M
September 30, 2014	9.238M
June 30, 2014	8.941M
March 31, 2014	8.671M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years

Start Trial

--

Minimum

--

Maximum

--

Average

--

Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks

Start Trial

Gilead Sciences, Inc.	9.147B
Insmed, Inc.	893.58M
United Therapeutics Corp.	644.60M
Vertex Pharmaceuticals, Inc.	2.008B
ACADIA Pharmaceuticals, Inc.	620.29M